GLOBAL DISPARITIES IN GENETIC TESTING ACCESS
“𝓐𝓭𝓿𝓪𝓷𝓬𝓮𝓭 𝓰𝓮𝓷𝓮𝓽𝓲𝓬 𝓽𝓸𝓸𝓵𝓼 𝓪𝓻𝓮 𝓹𝓸𝔀𝓮𝓻𝓯𝓾𝓵, 𝓫𝓾𝓽 𝓲𝓯 𝓪𝓬𝓬𝓮𝓼𝓼 𝓲𝓼 𝓵𝓲𝓶𝓲𝓽𝓮𝓭 𝓽𝓸 𝔀𝓮𝓪𝓵𝓽𝓱𝔂 𝓷𝓪𝓽𝓲𝓸𝓷𝓼, 𝓽𝓱𝓮 𝓹𝓻𝓸𝓶𝓲𝓼𝓮 𝓸𝓯 𝓹𝓻𝓮𝓬𝓲𝓼𝓲𝓸𝓷 𝓶𝓮𝓭𝓲𝓬𝓲𝓷𝓮 𝓫𝓮𝓬𝓸𝓶𝓮𝓼 𝓪 𝓹𝓻𝓲𝓿𝓲𝓵𝓮𝓰𝓮, 𝓷𝓸𝓽 𝓪 𝓻𝓲𝓰𝓱𝓽.” – Prof. Fatima Bosch
🧬 In recent years, rapid advancements in genomic technologies have redefined healthcare, offering deep insights into disease prevention, diagnosis, & treatment. Genetic testing; a linchpin of precision medicine, enables the detection of inherited conditions & disease predispositions. But while its benefits are immense, access to these tools remains deeply unequal across the globe.
🔹 Genetic testing access is shaped by intertwisted socioeconomic, geographic, & cultural barriers. High-income countries benefit from strong healthcare systems & expertise, while LMICs often face shortages in resources, personnel, & lab capacity. Access also varies within countries, with rural areas experiencing delays due to limited facilities and distance. Cultural stigmas, fear of discrimination, & low awareness further hinder testing uptake globally.
🔹 The effects are serious:
➡️ Delayed or missed diagnoses, especially for treatable hereditary conditions,
➡️ Higher morbidity & mortality in underserved or marginalized populations,
➡️ Exclusion from genomic research, skewing data & limiting the relevance of emerging therapies for diverse populations. For instance, underrepresented ethnic groups may harbor unique genetic variants. When excluded from studies, the treatments developed often fail to address their specific needs, widening health disparities.
🔹 Addressing disparities needs coordinated, multi-sectoral action. Governments & global bodies should subsidize genetic testing in LMICs. Partnerships can improve infrastructure & equity. Digital tools & mail-in kits reduce geographic barriers. Public campaigns must demystify testing and highlight its preventive value. Engaging community leaders fosters trust. Funders must support research on underrepresented groups to ensure precision medicine benefits all.
⚠️ In an Oystershell, the bottom line genetic testing holds enormous potential; but without equity in access, its promise remains unrealized for much of the world. Overcoming this imbalance is not just a scientific or technical challenge. It’s a matter of justice. By closing these gaps, we can move toward a future where genetic insight is a universal right, not a luxury.
Abubakar Abubakar ✍🏻
• Weng, Patricia L. et al. The American Journal of Human Genetics, Volume 108, Issue 2, 357 - 367.
• Martin, A.R., Kanai, M., Kamatani, Y. et al. Nat Genet 51, 584–591 (2019).
• Chansavang, A., Maalej, S., Narjoz, C., Loriot, M. A., & Pallet, N. (2020). Pharmacogenomics, 21(17), 1217–1226.
#GeneticTesting #HealthEquity #SocialJustice #PublicHealth #GeneticCounseling #Genomics #PrecisionMedicine #ART 🌍
